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INTRODUCTION 
The inter-particulate interactions between active pharmaceutical ingredients (API) 
and between APIs and co-formulated excipients play an important role in the 
performance of inhalation products.  However, accurate experimental assessment of 
surface energy and hence inter-particulate interactions has proved to be especially 
difficult using available techniques. The purpose of this study was to develop a 
framework whereby molecular crystal structures are utilized as the starting point for 
molecular modelling approaches to study the crystal morphology, surface chemistry 
and surface energy of the inhalation drug compound terbutaline sulfate (TBS). The 
molecular modelling approaches were subsequently compared with experimentally-
derived surface energy mapping, using finite dilution inverse gas chromatography 
surface energy analysis, both for validation purposes and to shed light on the 





The computational analysis was carried out utilizing the Cambridge Crystallographic 
Data Centre (CCDC) Mercury [1], BIOVIA Materials Studio [2] and HABIT98 [3]. The 
calculated attachment energies were normalised to that of the slowest growing face, 
i.e. with the largest surface area to determine relative growth rates per surface, and 
through this, a prediction of the crystal habit was generated. The digital workflow 
summarized in Figure 1 gives an overview of the main features of the analysis. 
 
Figure 1: A digital workflow highlighting the methodology from crystallographic 
structure to particle properties for the prediction of formulation performance 
 
Experimental method 
TBS single crystals were prepared by cooling crystallisation as follows: 0.32 g of 
TBS (Sigma Aldrich; purity ≥98%) was added to a mixture of 70% water and 30% 
ethanol (% by mass) to make 1 g of solution. This was then heated to 70°C to ensure 
complete solute dissolution and then cooled to 5°C and left for 2-3 days until 
crystallization occurred. An Olympus BX51 microscope was used to characterize the 
shape of the resultant crystals for comparison to the in-silico predicted crystal 
morphology. 
Surface energy (SE) analysis was conducted using a Surface Energy Analyser (iGC-
SEA, Surface Measurement Systems Ltd, UK). Non-polar probes (n-decane, n-
nonane, n-octane and n-heptane) and polar probes (chloroform, toluene, ethyl 
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acetate and acetone) were injected into the column at concentrations consistent with 
a range of surface coverages (between 0.5 up to 13% for all probes with the 
exception of n-decane that reached a maximum surface coverage of 4.5%). The 
dispersive (γd, non-polar) and acid-base (γab, polar) components of the surface 
energy were calculated using the Dorris-Gray method and the Peak Centre of Mass 
Parameter. All measurements were made in triplicate for non-micronized terbutaline 
sulfate used as supplied by AstraZeneca using IGC.  
RESULTS AND DISCUSSION 
Table 1: List of crystal surfaces, calculated attachment energies, % crystal surface 
area, together with the predicted whole particle surface energy compared with those 


















































Calculated surface energy (weighting with % surface area)  28.27 48.2 




Figure 2: Predicted morphology showing a plate-like crystal morphology with the 
surface chemistry of {010}, {100}, {001} and {110} surfaces (a) and experimentally 




Figure 3: Measured dispersive and total surface energy of terbutaline sulfate. 
 
The predicted morphology, shown in Figure 2 (a), based on the Attachment Energy 
model, shows a plate-like morphology with the {010} being the dominant form, along 
with the smaller {100}, {001} and {110} surfaces. The predicted morphology agrees 
well with the observed experimental crystal morphology grown in a mixture of 70% 
water and 30% ethanol at 5°C (see Figure 2 b).  
The IGC data showed that the surface energy decreased with increasing surface 
coverage (see Figure 3). The calculated dispersive and total surface energy tended 
to correlate better at a higher surface coverage comparing to low surface coverage 
(0.5%), for example the measured dispersive surface energy 32.8 (mJ/m2) at the 
surface coverage 13%, and the calculated dispersive surface energy 28.27 (mJ/m2). 
The predicted surface energy showed significant differences between the surface 
energies of individual crystal surfaces (Table 1, columns 6 and 7). The surface 
energies of the {110} and {001} forms were greatest whilst the surface energy of the 
{010} is the lowest. This agrees well with the surface chemistry analysis which 
indicates that the {110} and {001} forms have more polar and non-polar components 
exposed on the surfaces contributing to the dispersive and polar surface energy. 
Additionally, the calculation of the surface energy for the highest energy sites (the 
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{001} surfaces: 109 mJ/m2) correlated well with the experimental measurements at 
low surface coverage (103.3 mJ/m2), where the highest energy surface sites are 
probed (both from the crystallography and process-induced disorder). 
CONCLUSIONS 
This work demonstrates the utility of synthonic modelling approaches in 
understanding the surface properties of organic salt materials at the molecular scale. 
The ability to employ synthonic molecular modelling approaches for the salt 
terbutaline sulfate was validated through single crystal growth experiments and 
measured surface energy data using IGC. IGC tends to measure the highest energy 
surface sites, which corresponds well to the energy of the highest energy crystal 
face. The calculated dispersive and total surface energy tended to correlate better at 
a higher surface coverage comparing to low surface coverage (0.5%) in this study.  
The surface energy data measured using IGC was found to correlate well with the 
calculated surface energy of the most energetic crystal surface {001}, suggesting 
that this experimental technique tends to probe the higher energy surface sites. 
Further experimental measurement of surface energy by IGC is being employed in 
ongoing work to assess the face-specific heterogeneity of the surface energy 
distribution of TBS. The calculated surface energy analysis is very helpful for 
assessing and interpreting the measured IGC data, notably through its ability to both 
partition surface energies between the different morphological forms. The analysis 
has therefore shown the potential for a molecular modelling approach to study 
surface-surface contact forces when designing inhalation formulations. 
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